The 186-day exposure period comprised 28 days of dose escalation, with each dose administered 3 times per day as follows: 60 mg (days 1-7), 120 mg (days 8-14), 180 mg (days 15-21), and 300 mg (days 22-28). This exposure period was followed by 158 days of administration of ambroxol at 1.26 g per day (420 mg 3 times per day). Patients were issued ambroxol therapy in 2 batches, 1 at baseline and 1 at 93 days. Ambroxol tablets were donated by PRO.MED.CS Praha a. s. (Prague, Czech Republic).
Can it potentially help advanced cases of PD?
Dose of Ambraxol in trial
The 186-day exposure period comprised 28 days of dose escalation, with each dose administered 3 times per day as follows: 60 mg (days 1-7), 120 mg (days 8-14), 180 mg (days 15-21), and 300 mg (days 22-28). This exposure period was followed by 158 days of administration of ambroxol at 1.26 g per day (420 mg 3 times per day). Patients were issued ambroxol therapy in 2 batches, 1 at baseline and 1 at 93 days. Ambroxol tablets were donated by PRO.MED.CS Praha a. s. (Prague, Czech Republic).
i have had NO help in 9 yrs ii wil fly anywhere try ayything. i have bbeeeenn on waiting lisst for DBS nno action pleasee help!
Try daphney bryans B1 therapy book b1 thiamine in pill form benfotiamine ,, google it ,,,,, i find it helps
How do we contact you, pretty please?
Where can we contact u re this new drug?
Can people outside the UK & USA participate in either of these trials?
Hi there, best to contact them directly cureparkinsons.org.uk/ Good luck
Salam sizə işinizdə ugurlar mən orada yaşasaydım bu sınaqlarda iştirak edərdim ümidvaram ki parkinson xəstəliyinin müalicəsi tapılacaq. Çox sag olun
Przetłumacz na polski